11 Results for "

long QT syndrome

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "long QT syndrome" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B0387
CAS No.: 122647-32-9
Synonyms: U70226E
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Ibutilide (U70226E) fumarate, an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K + current (IKr) in AT-1 cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0387A
CAS No.: 122647-31-8
Synonyms: U70226E free base
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

Ibutilide (U70226E free base), an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K + current (IKr) in AT-1 cells .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1604
CAS No.: 60748-45-0
ATX-II is a selective sodium channel modulator toxin. ATX-II enhances late sodium current, prevents full sodium channel inactivation, and generates persistent current fractions. ATX-II has pro-arrhythmic effect. ATX-II slows intrinsic heart rate, prolongs QT interval and sinus node recovery time, and causes sinus pauses and arrests. ATX-II can be used for the research of atrial fibrillation, long QT syndrome, and long QT3 syndrome .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1604A
ATX-II TFA is a selective sodium channel modulator toxin. ATX-II TFA enhances late sodium current, prevents full sodium channel inactivation, and generates persistent current fractions. ATX-II TFA has pro-arrhythmic effect. ATX-II TFA slows intrinsic heart rate, prolongs QT interval and sinus node recovery time, and causes sinus pauses and arrests. ATX-II TFA can be used for the research of atrial fibrillation, long QT syndrome, and long QT3 syndrome .
loading...
    loading...
Cat. No.: HY-W516880
CAS No.: 73736-50-2
Synonyms: O-Demethylastemizole
Desmethylastemizole (O-Demethylastemizole) , a metabolite of Astemizole (HY-12532), is a β-hematin (βH) inhibitor. Desmethylastemizole has an antiplasmodium activity against P. falciparum with IC50 of 0.12, 0.11 and 0.06  μM for Pf3D7, PfDd2, and PfItG strains, respectively. Desmethylastemizole is also a Histamine H1 receptor antagonist. Desmethylastemizole significantly blocks hERG K + channels and also inhibits histone-lysine N-methyltransferase EZH2 activity. Desmethylastemizole can be used for long QT syndrome and malaria research .
loading...
    loading...
Cat. No.: HY-122024
CAS No.: 496793-75-0
Purity:  99.87%
Target:  

Potassium Channel

Research Areas:  

Cardiovascular Disease

AZSMO-23 is a potent hERG K + channel activator. AZSMO-23 activats WT hERG pre-pulse and tail current with EC50 values of 28.6, 11.2 µM, respectively. AZSMO-23 has the potential for the research of long QT syndrome .
loading...
    loading...
Cat. No.: HY-17504C
CAS No.: 1094100-06-7
(3R,5R)-Rosuvastatin is a hERG potassium channel blocker and HMG-CoA reductase inhibitor that prolongs the action potential duration and QT interval by accelerating channel inactivation, impairing channel folding, reducing hERG mRNA transcription, and promoting the degradation of mature and immature hERG channels. (3R,5R)-Rosuvastatin can be used for research on long QT syndrome .
loading...
    loading...
Cat. No.: HY-145992
CAS No.: 1008671-38-2
Purity:  99.03%
KCNQ1 activator-1 (compound 5) is a potent activator of KCNQ1 channel with an EC50 of 1.69 μM. KCNQ1 activator-1 has the potential for the research of long QT syndrome (LQTS) .
loading...
    loading...
Cat. No.: HY-121520
CAS No.: 132850-40-9
Docosahexaenoyl glycine is a PUFA analogue. Docosahexaenoyl glycine has activating effects on IKs channels and restore the function of IKs channels with LQT1 mutation .
loading...
    loading...
Cat. No.: HY-P701834
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KCNH2; HERG1; Prev. LQT2; Potassium Voltage-Gated Channel Subfamily H Eag-Related Member 2; HERG; Ether-A-Go-Go-Related Potassium Channel Protein; Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2; Voltage-Gated Channel Subfamily H Member 2; Voltage-Gated Inwardly Rectifying Potassium Channel KCNH2; Human Ether-A-Go-Go-Related Gene; Ether-A-Go-Go-Related Gene Potassium Channel 1; Uncharacterized Protein KCNH2; Voltage-Gated Potassium Channel Subunit Kv11.1; Human Ether-A-Go-Go-Related; Kv11.1; Potassium Channel HERG1; Erg1; Potassium Channel HERG; Ether-A-Go-Go-Related Protein 1; KCNH2 Protein; long QT syndrome Type 2; HERG-1; Eag-Related Protein 1; SQT1; Eag Homolog; ERG1; ERG-1; ERG; H-ERG; Potassium Voltage-Gated Channel Subfamily H Member 2; Potassium Channel, Voltage Gated Eag Related Subfamily H, Member 2
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P703937
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: KCNH2; HERG1; Prev. LQT2; Potassium Voltage-Gated Channel Subfamily H Eag-Related Member 2; HERG; Ether-A-Go-Go-Related Potassium Channel Protein; Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2; Voltage-Gated Channel Subfamily H Member 2; Voltage-Gated Inwardly Rectifying Potassium Channel KCNH2; Human Ether-A-Go-Go-Related Gene; Ether-A-Go-Go-Related Gene Potassium Channel 1; Uncharacterized Protein KCNH2; Voltage-Gated Potassium Channel Subunit Kv11.1; Human Ether-A-Go-Go-Related; Kv11.1; Potassium Channel HERG1; Erg1; Potassium Channel HERG; Ether-A-Go-Go-Related Protein 1; KCNH2 Protein; long QT syndrome Type 2; HERG-1; Eag-Related Protein 1; SQT1; Eag Homolog; ERG1; ERG-1; ERG; H-ERG; Potassium Voltage-Gated Channel Subfamily H Member 2; Potassium Channel, Voltage Gated Eag Related Subfamily H, Member 2
Species:  
Human
Source:  
HEK293
loading...
    loading...
  • 1